Terug
Ook genoteerd als
ARGNF
OTC
Dagbereik
€ 666,79
€ 677,85
52-Weeksbereik
€ 510,06
€ 934,62
Volume
256.342
50D / 200D Gem.
€ 791,83
/
€ 749,96
Vorige Slotkoers
€ 681,85
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 32,4 | 0,4 |
| P/B | 5,7 | 2,9 |
| ROE % | 20,2 | 3,9 |
| Net Margin % | 31,1 | 3,8 |
| Rev Growth 5Y % | 70,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 1.026,71
+51.5%
Low: € 858,00
High: € 1.317,00
Forward K/W
25,8
Forward WPA
€ 26,47
WPA Groei (sch.)
+0,0%
Omzet Sch.
6 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 59,47
€ 51,80 – € 67,36
|
11 B | 5 |
| FY2029 |
€ 51,95
€ 45,25 – € 58,84
|
9,8 B | 11 |
| FY2028 |
€ 45,30
€ 39,46 – € 51,32
|
8,5 B | 9 |
Belangrijkste Punten
Revenue grew 70,11% annually over 5 years — strong growth
Earnings grew 55,58% over the past year
ROE of 20,22% indicates high profitability
Net margin of 31,12% shows strong profitability
Debt/Equity of 0,01 — conservative balance sheet
Generating 844,30M in free cash flow
Groei
Revenue Growth (5Y)
70,11%
Revenue (1Y)90,12%
Earnings (1Y)55,58%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
20,22%
ROIC9,85%
Net Margin31,12%
Op. Margin23,35%
Veiligheid
Debt / Equity
0,01
Current Ratio5,23
Interest Coverage237,50
Waardering
P/E Ratio
32,35
P/B Ratio5,73
EV/EBITDA39,61
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 90,12% | Revenue Growth (3Y) | 84,27% |
| Earnings Growth (1Y) | 55,58% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 70,11% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4,16B | Net Income (TTM) | 1,30B |
| ROE | 20,22% | ROA | 14,93% |
| Gross Margin | 89,14% | Operating Margin | 23,35% |
| Net Margin | 31,12% | Free Cash Flow (TTM) | 844,30M |
| ROIC | 9,85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 5,23 |
| Interest Coverage | 237,50 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 32,35 | P/B Ratio | 5,73 |
| P/S Ratio | 10,07 | PEG Ratio | 0,77 |
| EV/EBITDA | 39,61 | Dividend Yield | 0,00% |
| Market Cap | 41,93B | Enterprise Value | 38,52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,16B | 2,19B | 1,23B | 410,75M | 497,28M |
| Net Income | 1,30B | 833,04M | -295,05M | -709,59M | -407,63M |
| EPS (Diluted) | 19,63 | 12,78 | -5,16 | -13,05 | -7,99 |
| Gross Profit | 3,71B | 1,96B | 1,11B | 381,32M | 497,28M |
| Operating Income | 972,46M | -21,65M | -425,05M | -720,34M | -348,75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8,68B | 6,20B | 4,54B | 3,13B | 2,85B |
| Total Liabilities | 1,36B | 704,24M | 444,95M | 320,56M | 316,05M |
| Shareholders' Equity | 7,32B | 5,50B | 4,10B | 2,81B | 2,53B |
| Total Debt | 83,49M | 39,05M | 20,00M | 12,43M | 11,47M |
| Cash & Equivalents | 3,49B | 1,50B | 2,05B | 800,74M | 1,33B |
| Current Assets | 6,90B | 4,88B | 4,12B | 2,77B | 2,54B |
| Current Liabilities | 1,32B | 669,92M | 422,99M | 302,28M | 301,24M |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recente Activiteit
Ingestapt
Growth Investing (Philip Fisher)
Mar 24, 2026
Ingestapt
Full Throttle
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026